Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia

Mise à jour : Il y a 4 ans
Référence : NCT00354809

Femme et Homme

Extrait

This study is designed to determine whether morning doses of GW679769, taken daily for 1 to 9 days, will promote sleep during the following night without significant post-dose thinking impairment and drowsiness in subjects with primary insomnia.


Critère d'inclusion

  • Sleep Initiation and Maintenance Disorders ,Insomnia

Liens